27 Nov 2019 --- A collaboration between microbial sciences company Seed Health and Atmo Biosciences – a digital health company – will see an ingestible gas-sensing capsule technology monitor key gases produced within the gut in real-time. Atmo’s gas capsule, which tracks location-specific gases through the human gastrointestinal (GI) tract, will be used to examine the Daily Synbiotic – the flagship probiotic of Seed, the consumer health division of Seed Health. The first trial will evaluate the impact of probiotics on the gut microbiome after antibiotic use.
